In this week’s episode of Elon, Inc., we conclude a series of “jealousy interviews” where we talk to authors of Elon Musk stories we wish we had written. This time, Bloomberg News Musk reporter Dana Hull chats with Kirsten Grind of the New York Times about her May exposé on the alleged campaign trail drug habits of a certain entrepreneur-turned-aspiring political kingmaker.
The conversation covers not only Musk’s reported drug use (which he has denied) but the prevalence of drugs in Silicon Valley and across the tech industry as well. “All these tech guys think they can disrupt everything and they want to also disrupt their health,” Grind says. “So they kind of think they can medicate themselves a lot of the times.” Hull and Grind also talk about the broader themes of Musk’s salad days, back when he juggled not only a grueling schedule but private legal battles involving his many children.
See omnystudio.com/listener for privacy information.
